Our Blog | Quotient Sciences

Latest Press Release

ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19

Spotlight on Nottingham - Q&A with Clare Preskey and Andy Lewis

5 / 16 posts displayed

Site Spotlight

Spotlight on Reading, UK - Q&A with Chris Landeg, Site Head of Quotient Sciences Reading
HPAPI's

Understanding the Challenges of Working with Products containing High-Potency Active Pharmaceutical Ingredients (HPAPIs)
Formulation Development

How to Avoid Losing Time in Development when Bridging from First-in-Human Dosage Form to Robust and Scalable Phase II Drug Products
Scientific resources

Quotient's scientific publications in 2018
Clinical pharmacology

How to recruit specialty volunteer populations for early-phase clinical research

Share Your Development Challenge with our Scientists

Let's Talk

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.

Latest Press Release

Spotlight on Nottingham - Q&A with Clare Preskey and Andy Lewis

Spotlight on Reading, UK - Q&A with Chris Landeg, Site Head of Quotient Sciences Reading

Understanding the Challenges of Working with Products containing High-Potency Active Pharmaceutical Ingredients (HPAPIs)

How to Avoid Losing Time in Development when Bridging from First-in-Human Dosage Form to Robust and Scalable Phase II Drug Products

Quotient's scientific publications in 2018

How to recruit specialty volunteer populations for early-phase clinical research

Share Your Development Challenge with our Scientists